Compare BNTC & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNTC | AIRS |
|---|---|---|
| Founded | 1995 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 405.7M | 166.3M |
| IPO Year | N/A | 2021 |
| Metric | BNTC | AIRS |
|---|---|---|
| Price | $13.05 | $2.17 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $28.25 | $3.75 |
| AVG Volume (30 Days) | 254.1K | ★ 676.7K |
| Earning Date | 02-13-2026 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $157,554,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.70 | $1.53 |
| 52 Week High | $17.15 | $12.00 |
| Indicator | BNTC | AIRS |
|---|---|---|
| Relative Strength Index (RSI) | 52.41 | 24.60 |
| Support Level | $10.99 | $2.07 |
| Resistance Level | $13.36 | $2.36 |
| Average True Range (ATR) | 0.97 | 0.26 |
| MACD | 0.11 | 0.11 |
| Stochastic Oscillator | 83.20 | 7.75 |
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.